基本信息
浏览量:239
职业迁徙
个人简介
Dr Haralabos Kalofonos is a Professor of Medical Oncology, Director of the Division of Oncology and Clinical Oncology Laboratory at the University of Patras, Greece. His work is multi-dimensional and includes clinical practice and basic science. Dr. Kalofonos participates in the design of clinical trials (phase II and III) organized by Cooperative Groups as well as in international multi-centered clinical trials phase II, III and IV, to evaluate the therapeutic efficacy of new anticancer agents and/or their combination with chemotherapy.
Furthermore, Dr. Kalofonos conducts research on patients’ quality of life during and after chemotherapy or targeted therapy in order to improve treatment’s serious adverse events such as pain, anemia, depression, etc. His continuing interest on the role the psychosocial factors have in patients’ total function has led to the development of Quality of Life and Supportive Care Multidisciplinary Group.
Regarding basic research, Dr. Kalofonos has considerable experience in the development and applications of monoclonal antibodies for cancer treatment. Furthermore, his scientific interest is also focused on research for markers with prognostic and predictive role in cancer using molecular oncology techniques. Clinical Oncology Laboratory has developed a bank of fresh frozen human tissues including colon cancer and non small cell lung cancer.
Clinical practice as well as basic research will contribute to understanding carcinogenesis and tumor development for cancer management improvement. Dr. Kalofonos collaborates with several Departments of the University of Patras as also with Universities, Hospitals and Institutes in Greece and abroad (Medical Research Council – Hammersmith Hospital, UK, Institute Tumori Milan, Stony Brook University, USA, etc.).
Furthermore, Dr. Kalofonos conducts research on patients’ quality of life during and after chemotherapy or targeted therapy in order to improve treatment’s serious adverse events such as pain, anemia, depression, etc. His continuing interest on the role the psychosocial factors have in patients’ total function has led to the development of Quality of Life and Supportive Care Multidisciplinary Group.
Regarding basic research, Dr. Kalofonos has considerable experience in the development and applications of monoclonal antibodies for cancer treatment. Furthermore, his scientific interest is also focused on research for markers with prognostic and predictive role in cancer using molecular oncology techniques. Clinical Oncology Laboratory has developed a bank of fresh frozen human tissues including colon cancer and non small cell lung cancer.
Clinical practice as well as basic research will contribute to understanding carcinogenesis and tumor development for cancer management improvement. Dr. Kalofonos collaborates with several Departments of the University of Patras as also with Universities, Hospitals and Institutes in Greece and abroad (Medical Research Council – Hammersmith Hospital, UK, Institute Tumori Milan, Stony Brook University, USA, etc.).
研究兴趣
论文共 604 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Andreas A. Argyriou,Jordi Bruna,Foteini Kalofonou,Roser Velasco,Pantelis Litsardopoulos,Montse Alemany, Garifallia G. Anastopoulou,Haralabos P. Kalofonos
Cancer Researchno. 5_Supplement (2023): P2-26
引用0浏览0引用
0
0
Konstantinos E Siatis, Efstathia Giannopoulou,Dimitra Manou,Panagiotis Sarantis,Michalis V Karamouzis,Sofia Raftopoulou, Konstantinos Fasseas, Fatimah Mohammed Alzahrani,Haralabos P Kalofonos,Achilleas D Theocharis
John D Mitsou,Vivian Tseveleki,Foteinos-Ioannis Dimitrakopoulos, Konstantinos Konstantinidis,Haralabos Kalofonos
Cancersno. 15 (2023)
引用0浏览0WOS引用
0
0
JTO CLINICAL AND RESEARCH REPORTSno. 1 (2023): 100433-100433
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn